IL10 and non-small cell lung carcinoma: Matrine has been shown to down-regulate the expression levels of IL-4, Arg-1, and IL-10 by blocking the PI3K/Akt/mTOR signaling pathway, consequently suppressing the polarization of M2-TAM and the metastasis of NSCLC (122).